|

Date first patient entered: TBA
Target Accrual: 100
Aim: This prospective study will test the following hypotheses in patients with stage I-II low grade marginal zone (MZ) lymphoma:
a) Involved Field Radiotherapy will produce a complete response rate of > 90%
b) Radiotherapy will be associated with a locoregional progression of < 20% after 10 years
c) Death from MZ lymphoma will occur in < 40% of patients within 10 years of radiotherapy
Trial Contacts:
Assoc Prof Michael MacManus
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne
Fax: +61 3 9656 1424
Dr Andrew Wirth
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne
Fax: +61 3 9656 1424
Dr John Seymour
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne
Peter MacCallum Cancer Centre
Fax: +61 3 9656 1424
Trial Centre Data Manager
Teresa Morgan
Centre of Bio Statistical & Clinical Trials
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne
Fax: +61 3 9656 1420
More information
[ Open
Trials - Home ]
 |